Cargando…

Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer

BACKGROUND: Promoter methylation has been observed for several genes in association with cancer development and progression. Hypermethylation mediated-silencing of tumor suppressor genes (TSGs) may contribute to breast cancer pathogenesis. The present study was conducted to investigate the promoter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Prasant, Masroor, Mirza, Nandi, Kajal, Kaza, R C M, Jain, S K, Khurana, Nita, Saxena, Alpana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980932/ https://www.ncbi.nlm.nih.gov/pubmed/29480000 http://dx.doi.org/10.22034/APJCP.2018.19.2.443

Ejemplares similares

Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK
por: Bai, Jian, et al.
Publicado: (2016)

Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer
por: Vu, Trang Lan, et al.
Publicado: (2018)

Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients
por: Beg, Mirza Masroor Ali, et al.
Publicado: (2019)

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
por: Liu, Yang, et al.
Publicado: (2007)

Dioscin induces demethylation of DAPK-1 and RASSF-1alpha genes via the antioxidant capacity, resulting in apoptosis of bladder cancer T24 cells
por: Zhou, Qiang, et al.
Publicado: (2017)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

Clinical utility of RASSF1A methylation in human malignancies
por: Grawenda, A M, et al.
Publicado: (2015)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

Regulation of the Expression of DAPK1 by SUMO Pathway
por: Wang, Qingshui, et al.
Publicado: (2019)

The prognostic significance of DAPK1 in bladder cancer
por: Xie, Jian-Yun, et al.
Publicado: (2017)

Association between DAPK1 Promoter Methylation and Cervical Cancer: A Meta-Analysis
por: Xiong, Jiaqiang, et al.
Publicado: (2014)

Methylation analysis of the DAPK1 gene in imatinib-resistant chronic myeloid leukemia patients
por: CELIK, SELCEN, et al.
Publicado: (2015)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

miR-486-5p: A Prognostic Biomarker for Chronic Myeloid Leukemia
por: Ninawe, Anupama, et al.
Publicado: (2021)

Tumor Suppressor DAPK1 Catalyzes Adhesion Assembly on Rigid but Anoikis on Soft Matrices
por: Qin, Ruifang, et al.
Publicado: (2022)

DAPK1 as an independent prognostic marker in liver cancer
por: Li, Ling, et al.
Publicado: (2017)

Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis
por: Yuan, Wenzheng, et al.
Publicado: (2017)

Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation
por: Tian, Yihao, et al.
Publicado: (2011)

Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients
por: Mir, Rashid, et al.
Publicado: (2016)

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer
por: Christoph, F, et al.
Publicado: (2006)

DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis
por: Agodi, Antonella, et al.
Publicado: (2015)

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)

Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis
por: Ghalkhani, Esmat, et al.
Publicado: (2021)

DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
por: Wang, Shan, et al.
Publicado: (2016)

Identification of DAPK1 as an autophagy-related biomarker for myotonic dystrophy type 1
por: Hu, Min, et al.
Publicado: (2022)

RASSF1A Suppression as a Potential Regulator of Mechano-Pathobiology Associated with Mammographic Density in BRCA Mutation Carriers
por: Reye, Gina, et al.
Publicado: (2021)

Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma
por: Zhang, Jian, et al.
Publicado: (2018)

Diagnostic Value of DAPK Methylation for Nasopharyngeal Carcinoma: Meta-Analysis
por: Lao, Thuan Duc, et al.
Publicado: (2023)

HIC1 and RassF1A Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer
por: Chen, Chih-Cheng, et al.
Publicado: (2018)

β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients
por: Schirosi, Laura, et al.
Publicado: (2016)

The impact of the RASSF1C and PIWIL1 on DNA methylation: the identification of GMIP as a tumor suppressor
por: Amaar, Yousef G., et al.
Publicado: (2020)

KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells
por: Frazzi, Raffaele, et al.
Publicado: (2022)

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver
por: Di Gioia, Sonia, et al.
Publicado: (2006)

Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
por: Muñoz, Jorge, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o6rogva8vkc4stupuv2fm55q0t